Hyperliquid Strategies has increased the maximum value of its equity financing facility with Chardan Capital Markets from $1bn to $2.5bn, according to a filing with the United States Securities and Exchange Commission (SEC).
The Nasdaq-listed company can raise money over time by selling newly issued PURR shares to Chardan. The expanded arrangement does not mean Hyperliquid Strategies has received $2.5bn, completed a share offering of that size or committed the full amount to buying HYPE, the native token of the Hyperliquid network.
The amendment to the ChEF purchase agreement was signed by Hyperliquid Strategies and Chardan on 1 September. The original agreement was dated 22 October 2025, and the latest change adds $1.5bn to the total potential commitment.
Under the agreement, Chardan can buy newly issued common shares after Hyperliquid Strategies submits qualifying purchase notices. The company retains control over when sales take place and how many shares are issued.
Its SEC disclosures say those decisions will be based on factors including market conditions, PURR’s trading price and management’s view of how any funds raised should be used.
The facility is not a conventional loan. Share sales do not create principal repayments or interest costs, but they exchange equity for cash and can reduce the proportion of the company represented by each existing share.
There is also no guarantee that Chardan will purchase $2.5bn of stock. Any transactions remain subject to the terms, conditions and limitations of the agreement, meaning the amount ultimately raised could be significantly lower than the maximum facility size.
Hyperliquid Strategies has previously said in its prospectus that proceeds from equity-facility sales may be used for general corporate purposes, including possible purchases of HYPE.
That wording gives management broad discretion. It does not set a minimum amount for HYPE purchases, a deadline for buying the token or a fixed target for the number of tokens to be acquired. Funds could instead be directed towards operating costs, transaction expenses or other corporate needs.
The Form 8-K filed on 1 September did not announce a new HYPE purchase. It also did not state whether the company had already sold shares using the additional $1.5bn of capacity.
Hyperliquid Strategies said it held 29.3 million HYPE as of 19 August. Since completing its business combination in December 2025, it had spent $773.4m to buy about 16.5 million tokens at an average price of $46.77, as reported by crypto.news.
The company reported $149.9m in cash at the end of June and said it had no debt. Its HYPE holdings had more than doubled from the approximately 12.6 million tokens linked to the company’s formation.
The transaction that created Hyperliquid Strategies included $305m in cash alongside the initial HYPE contribution. Equity financing has since become a central part of the company’s strategy for accumulating the token.
Share issuance limit
The amendment also includes an exchange cap that becomes relevant once total share sales through the facility reach $1bn.
After that point, Hyperliquid Strategies will generally be unable to sell more than 42,641,847 shares at prices below $12.02. The figure represents 19.99% of the common shares outstanding immediately before the amendment was signed.
The company could exceed the limit if shareholders approve further share issuances in line with Nasdaq rules. The restriction could also stop applying if shareholder approval is not required under an available Nasdaq provision.
At $12.02 per share, the maximum 42,641,847 shares would generate about $512.5m in gross proceeds. That calculation excludes fees and assumes all the shares are sold at the stated price.
The relationship between the share limit and the larger $2.5bn facility could restrict access to the full commitment if PURR trades below $12.02. Raising the entire amount may require higher sale prices, shareholder approval or an applicable exception under Nasdaq rules.
The impact on existing investors will depend on the timing and scale of individual share sales. If shares are sold at lower prices, more stock must be issued to raise the same amount of money, increasing potential dilution.
PURR closed at $11.36 on 1 September, down about 7.3% in regular trading. The stock opened at $11.76 and moved between $11.03 and $12.31, while trading volume was approximately 24.3 million shares.
That closing price was below the amendment’s $12.02 reference level. However, the market price alone does not trigger the exchange cap. The restriction applies to completed sales below that level after cumulative purchases under the facility have reached $1bn.
